Invention Grant
US08088784B2 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
失效
用作酪氨酸激酶抑制剂治疗癌症的4-（3-氨基吡唑）嘧啶衍生物
- Patent Title: 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
- Patent Title (中): 用作酪氨酸激酶抑制剂治疗癌症的4-（3-氨基吡唑）嘧啶衍生物
-
Application No.: US12713695Application Date: 2010-02-26
-
Publication No.: US08088784B2Publication Date: 2012-01-03
- Inventor: Xiaomei Feng , Huiping Guan , Ying Kang , Stephanos Ioannidis , Bo Peng , Mei Su , Bin Wang , Tao Wang , Hai-Jun Zhang
- Applicant: Xiaomei Feng , Huiping Guan , Ying Kang , Stephanos Ioannidis , Bo Peng , Mei Su , Bin Wang , Tao Wang , Hai-Jun Zhang
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61K31/506
Abstract:
This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
Public/Granted literature
Information query
